Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

Announcement on the Implementation of Directors’ and Senior Management Members’ Remuneration in 2025 and the Plan for 2026

· Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Implementation of Directors’ and Senior Management Members’ Remuneration in 2025 and the Plan for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment